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months following unblinding showed a decrease of BP in the RDN
arms over time and an increase in BP in the control/non-crossover arm
from 6 to 12 months as assessed by both ofﬁce and ambulatory BP
(Figure). Outcomes at 24 months, including ofﬁce and ambulatory BP,
available at TCT 2015, will be important to assess whether this pattern
is maintained. Long-term safety will also be presented.
CONCLUSIONS The ofﬁce systolic BP reduction in the RDN arm
continued to increase between 6 and 12 months while the opposite
relationship existed in the non-crossover patients. Outcomes at
24 months of unblinded treated subjects and non-treated control
subjects will provide new insights to guide our continued under-
standing of the effects of patient selection, medication burden, and
medication adherence in patients with treatment-resistant hyperten-
sion as well as conﬁrm long-term safety in this large population
treated with RDN.
CATEGORIES ENDOVASCULAR: Hypertension Therapies and Renal
Denervation
KEYWORDS Renal denervationTCT-84
Enhanced Circumferential Ablation using a Multi-electrode Bipolar/
Unipolar Over-the -Wire Renal Denervation RF Catheter System with
Closed Loop Sensing
Abraham R. Tzafriri,1 Lynn Bailey,2 John Keating,2
Fernando Garcia-Polite,2 Peter Markham,1 David Prutchi,3
Elazer R. Edelman4
1CBSET Inc., Lexington, MA; 2CBSET, Inc., Lexington, MA; 3Renal
Dynamics, Mount Laurel, NJ; 4Harvard-MIT Biomedical Engineering
Center, Cambridge, Massachusetts
BACKGROUND Posthoc analysis of SYMPLICITY HTN-3 has revealed a
trend for greater blood pressure reductions with increasing number of
ablations and highlighted the difﬁculty of achieving uniform and
circumferential ablation pattern using single electrode renal dener-
vation catheters. We examined whether iterative low power multi-
electrode bipolar-unipolar treatments based on local closed-loop
temperature sensing can provide effective four quadrant ablations.
METHODS Ten porcine renal arteries were treated once (n¼4) proxi-
mally or twice in sequence (n¼6) w6mm distal to the aortic ostium of
the renal artery using the ReDy system with a 72C set point (1.10.5
W, n¼10). A low proﬁle, 9-electrode, over-the-wire, RF ‘basket’ catheter
with closed loop temperature control, and a smart generator delivers
a 60sec sequence of bipolar and unipolar treatments designed to
ensure that each electrode meets a temperature-duration objective.
Catheters were advanced into the renal artery and positioned for
treatment using a 6-Fr guiding sheath under ﬂuoroscopic guidance.
In the dual treatment group the catheter was retracted half a basket
length after the ﬁrst treatment. At 7 days post treatment, kidneys
were harvested for norepinephrine (NEPI) quantiﬁcation and arteries
processed for histopathology. Post treatment NEPI levels were evalu-
ated relative to our published baseline levels (666222 ng/g, n¼12)
to calculate percent reductions. Automated image processing of H&Estained tissue sections estimated the percentage of affected circum-
ference up to a depth of 5 mm from the lumen.
RESULTS There was no angiographic evidence of acute dissection,
perforation, or occlusion at the time of the procedure or subsequently.
Histologically all treated arterial sections exhibited advanced re-
endothelialization, with progressive arterial and peri-arterial repair,
and no evidence of adverse effects on arteries or surrounding tissue.
Summation of ablation effects over multiple tissue sections revealed
that a larger percentage of the total circumferential arc was affected
by dual treatments compared to single treatments up to 3 mm from
the lumen. The difference between single and dual treatments was
particularly pronounced up to 1 mm away from the lumen, 53.531.6%
vs 87.511.2% (p¼0.11) and appeared to predict relative NEPI reduc-
tion, 60.638.5% (p¼0.03) vs 88.117.0% drop (p<0.001).
CONCLUSIONS We and others have argued for distal treatments
based on the relative accessibility of target nerves, yet such treat-
ments carry greater risk of affecting surrounding organs, particularly
close to the hilus. The data herein illustrate that low power dual distal
treatments using the Renal Dynamics ReDy system provide effective
circumferential ablation without affecting arterial patency or sur-
rounding organs.
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BACKGROUND Percutaneous sympathetic renal artery denervation is
available for the treatment of patients with resistant hypertension.
We further investigated the safety and efﬁcacy of a multi-electrode
renal denervation system (EnligHTN) in patients with severe un-
controlled hypertension.
METHODS The EnligHTN-II study is a post-market clinical investiga-
tion in which patients were assigned to one of three groups; Group A,
ofﬁce systolic BP (OSBP) 160 mmHg and estimated glomerular
ﬁltration rate (eGFR) 45 mL/min per 1.73 m2, Group B, OSBP 140-
159 mmHg and eGFR 45 mL/min per 1.73 m2 and Group C,
OSBP 140 mmHg and eGFR 15 mL/min per 1.73 m2. For all three
groups subjects were required to be on at least 3 anti-hypertensive
medications (including 1 diuretic), or to have documented drug
intolerance such that they are unable to take 3 anti-hypertensive
drugs. Responder analysis was also performed using a 5mmHg
reduction in ambulatory systolic measurement to deﬁne responders.
RESULTS 133 patients from Group A (average age 61.6  9.5 yrs taking
on average 4.3 2.3 anti-hypertensive medications) were included.
Bilateral renal nerve ablation was performed using a percutaneous
femoral approach. Baseline average OSBP was 181.9  16 mmHg,
average ofﬁce diastolic BP (ODBP) was 97.8  15.9 mmHg, average
24hr ambulatory SBP (ASBP) was 159.4  17 mmHg, and average 24hr
ambulatory DBP (ADBP) was 88.7  12.9 mmHg. At present, 119 6-
month and 88 12-month follow-up visits are completed. The average
reduction in OSBP/ODBP was 18.5/8.4 mmHg and 18.2/9.5 mmHg at 6-
and 12-month follow up respectively (p<0.0001 for all). The average
reduction in ASBP/ADBP was 7.1 /3.8 mmHg (p<0.0001 for both) and
9.8 /4.2 mmHg (p<0.001 for both) at 6 and 12M follow up respectively.
Neither eGFR nor serum creatinine changed signiﬁcantly from base-
line at either 6 or 12-months follow up. The following baseline factors
were associated with the responder group at the 90% conﬁdence
level: younger age, less sleep apnea, higher eGFR, lower serum
creatinine, higher systolic & diastolic ambulatory pressures.
CONCLUSIONS In this real world, post-marketing study we demon-
strate that multi-electrode renal denervation results in durable, highly
signiﬁcant and safe lowering of both ofﬁce BP and ambulatory BP
parameters in patients with severe uncontrolled hypertension up to 12
months following treatment.
